Today, Mediclinic International PLC (MDC) Receives Consensus Rating of “Hold” from Analysts

Today, Mediclinic International PLC (MDC) Receives Consensus Rating of “Hold” from Analysts
Shares of Mediclinic International PLC (LON:MDC) have earned an average rating of “Hold” from the ten analysts that are covering the stock. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is GBX 941.22 ($11.76).

MDC has been the topic of several recent analyst reports. Jefferies Group cut their price target on Mediclinic International PLC from GBX 833 ($10.41) to GBX 812 ($10.14) and set a “hold” rating on the stock in a research note on Wednesday, September 28th. Credit Suisse Group AG cut their price target on Mediclinic International PLC from GBX 1,120 ($13.99) to GBX 1,045 ($13.06) and set an “outperform” rating on the stock in a research note on Friday, November 11th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a GBX 1,160 ($14.49) price target on shares of Mediclinic International PLC in a research note on Tuesday, August 23rd. HSBC cut their price target on Mediclinic International PLC from GBX 920 ($11.49) to GBX 745 ($9.31) and set a “reduce” rating on the stock in a research note on Friday, November 11th. Finally, Macquarie cut their price target on Mediclinic International PLC from GBX 970 ($12.12) to GBX 830 ($10.37) and set a “neutral” rating on the stock in a research note on Wednesday.

Shares of Mediclinic International PLC (LON:MDC) opened at 732.50 on Monday. The firm’s 50-day moving average price is GBX 851.43 and its 200-day moving average price is GBX 949.05. Mediclinic International PLC has a 52-week low of GBX 721.50 and a 52-week high of GBX 1,125.00. The firm’s market capitalization is GBX 5.40 billion.

Related posts

Leave a Comment